← Leaderboard
BSX
Ticker
BSX
Congressional Trades
76
by 11 members
Buys
22
29%
Sells
41
54%
Total Volume
$1.2M
midpoint
Unique Traders
11
members
Party Breakdown
Democrats48 · 63%
Republicans28 · 37%
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthMODERATEBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
Democrat ←
Month
→ Republican
—
Feb '23
0▲1▼
0▲1▼
Mar '23
—
0▲1▼
Apr '23
0▲1▼
1▲2▼
May '23
—
—
Apr '24
0▲5▼
1▲
Oct '24
—
—
Dec '24
1▲
0▲1▼
Jan '25
—
1▲2▼
Feb '25⚡
2▲
1▲2▼
Mar '25⚡
1▲
1▲2▼
Apr '25
0▲2▼
0▲2▼
May '25
0▲2▼
0▲6▼
Jun '25
—
0▲3▼
Jul '25
—
—
Aug '25
0▲2▼
0▲2▼
Sep '25
—
2▲1▼
Oct '25⚡
2▲7▼
2▲
Nov '25
—
0▲2▼
Dec '25
0▲2▼
3▲1▼
Jan '26
—
3▲3▼
Feb '26
—
1▲1▼
Mar '26
—
Democrats16▲32▼Net sellers
vs
Republicans6▲22▼Net sellers
Net buyingNet selling⚡ Party split
🏛️ Federal Contracts
all →- 2026-04-29$249KDepartment of Veterans AffairsTHERASPHERE Y-90 GLASS MICROSPHERES
- 2026-04-28$38KDepartment of Veterans AffairsFARPULSE ABLIATION SYSTEM PM
- 2026-04-22$20KDepartment of Health and Human ServicesTHE PURPOSE OF THIS PURCHASE ORDER IS TO SUPPLY NHLBI WITH A SERVICE CONTRACT FOR ITS INTRAVASCULAR ULTRASOUND (IVUS) MACHINE.
- 2026-04-07$311KDepartment of Veterans AffairsTHERASPHERE
- 2026-04-01$5KDepartment of Veterans AffairsEXALT D CONTROLLER LEASE
- 2026-03-24$31KDepartment of Veterans AffairsIMPLANT
- 2026-03-10$78KDepartment of Veterans AffairsSUPPLY:ELUVIA US STENTS
- 2026-03-05$290KDepartment of Veterans AffairsTHERASPHERE YTTRIUM-90 (Y-90) GLASS MICROSPHERES QTY: 14 EACH
- 2026-03-04$17KDepartment of Veterans AffairsSURGICAL IMPLANT:
- 2026-02-26$22KDepartment of Veterans AffairsIMPLANT AXIOS ELECTROCAUTERY
💼 Lobbying Filings
all →- 2026-04-20$642KBOSTON SCIENTIFIC CORPORATIONMedical device procurement and supply chain resiliency. Ensuring VHA patient access to Med Tech as VHA manages supply chain and upgrades its medical surgery and prosthetics procurement contracting. Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives. VA Authorization Bill of 2025- Specifically, H.R. 6549 The VA Contracting and Procurement Act. This bill would reform VAs contracting process by modernizing medical implant acquisition and consolidating billing for surgical procedures to enhance delivery of care to veterans. FY2027 Appropriations: Advocacy efforts on including report language in Labor-HHS to advance non-opioid, evidence-based pain management and in VA/DoD accounts to support modernization of procurement processes, including a transparent product add cycle and a streamlined single purchase order mechanism. OECD 2 Pillar Framework Implementation - International t
- 2026-04-20$80KBOSTON SCIENTIFIC CORPORATIONIssues concerning Medicare reimbursement, AI and medical technology. Advocacy concerning tax issues. Advocacy concerning trade issues.
- 2026-04-20$60KBOSTON SCIENTIFICInterntational tax reform, TCJA reauthorization
- 2026-04-17$0BOSTON SCIENTIFIC (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA)Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R.10136 - Promoting Fairness for Medicare Providers Act of 2024.
- 2026-04-15$20KBOSTON SCIENTIFIC CORPORATIONMedical Supply Chain program reforms HR 6549, VA Contracting and Procurement Act
- 2026-01-21$60KBOSTON SCIENTIFICInterntational tax reform, TCJA reauthorization
- 2026-01-20$80KBOSTON SCIENTIFIC CORPORATIONIssues concerning Medicare reimbursement, AI and medical technology. Advocacy concerning tax issues. Advocacy concerning trade issues.
- 2026-01-20$0BOSTON SCIENTIFIC (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA)Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R.10136 - Promoting Fairness for Medicare Providers Act of 2024.
- 2026-01-16$570KBOSTON SCIENTIFIC CORPORATIONEnsuring Patient Access to Critical Breakthrough Products Act of 2025(H.R. 5343 and S.1717) - Legislation to create automatic CMS coverage for devices approved via FDA's breakthrough pathway. (CMS rulemaking for Transitional Coverage of Emerging Technologies (TCET) - advocacy for a new, voluntary Transitional Coverage of Emerging Technologies (TCET) pathway that provides national Medicare coverage for Breakthrough-designated technologies, beginning on the date of FDA market authorization.) The Patient Access to Innovative New Technologies Act (PAINT Act) -- proposed legislation that aims to expand access to new medical technologies by improving the Medicare New Technology Add-on Payment (NTAP) program. It would create a single deadline for products in an alternative pathway, ensure breakthrough devices are eligible for conditional approval under NTAP, and prevent disruption in Medicare beneficiaries' access to new treatments. 2025 Reauthorization of the SUPPORT for Patients and Communi
- 2026-01-12$12KHOLLIER & ASSOCIATES ON BEHALF OF BOSTON SCIENTIFICReauthorization of TCJA; International tax proposals
Congressional Momentum
buy vs. sell pressureNEUTRALScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Last 30 Days
No trades
Last 90 Days
–55
4 buys6 total2 sells
$81K buys · $65K sells
All-Time
▼21
22 buys76 total54 sells
$250K buys · $954K sells
Cumulative Net Position (buy vol − sell vol)
-$704K
2023-0276 trades plotted2026-03
Trade Activity Timeline
Congressional buys & sells by month · last 22 months w/ activity
23/02
23/03
23/04
23/05
24/04
24/10
24/12
25/01
25/02
25/03
25/04
25/05
25/06
25/07
25/08
25/09
25/10
25/11
25/12
26/01
26/02
26/03
BuysSellsOtherHigh-volume month
Who Moved First
each row = one member · sorted by earliest disclosed trade7 buyers ·11 sellers
BuySellOtherDot size ∝ trade size · top 11 most-active traders shown
All Disclosed Trades
| Date | Member | Action | Amount | Filing Delay |
|---|---|---|---|---|
| 2026-03-30 | DRo Khanna | BUY | $15K – $50K | 8d |
| 2026-03-23 | DRo Khanna | SELL | $15K – $50K | 15d |
| 2026-02-10 | DGilbert Cisneros | BUY | $1K – $15K | 28d |
| 2026-02-24 | DRo Khanna | SELL | $15K – $50K | 13d |
| 2026-02-17 | DRo Khanna | BUY | $15K – $50K | 20d |
| 2026-02-10 | DGilbert Cisneros | BUY | $1K – $15K | 27d |
| 2026-02-06 | DRo Khanna | SELL | $1K – $15K | 31d |
| 2026-02-05 | DRo Khanna | SELL | $15K – $50K | 32d |
| 2026-01-30 | DGilbert Cisneros | BUY | $1K – $15K | 17d |
| 2026-01-30 | DGilbert Cisneros | BUY | $1K – $15K | 14d |
| 2026-01-29 | DRo Khanna | BUY | $15K – $50K | 8d |
| 2026-01-06 | DRo Khanna | SELL | $1K – $15K | 31d |
| 2025-12-17 | RJohn Boozman | PARTIAL_SELL | $1K – $15K | 27d |
| 2025-12-24 | DGilbert Cisneros | SELL | $1K – $15K | 20d |
| 2025-12-17 | RJohn Boozman | PARTIAL_SELL | $1K – $15K | 27d |
| 2025-12-24 | DGilbert Cisneros | SELL | $1K – $15K | 19d |
| 2025-11-18 | DGilbert Cisneros | BUY | $1K – $15K | 28d |
| 2025-11-18 | DGilbert Cisneros | BUY | $1K – $15K | 27d |
| 2025-10-31 | RLisa McClain | SELL | $1K – $15K | 24d |
| 2025-10-30 | RLisa McClain | BUY | $1K – $15K | 25d |
| 2025-10-30 | RLisa McClain | SELL | $1K – $15K | 25d |
| 2025-10-31 | RLisa McClain | SELL | $1K – $15K | 21d |
| 2025-10-30 | RLisa McClain | SELL | $1K – $15K | 22d |
| 2025-10-30 | RLisa McClain | BUY | $1K – $15K | 22d |
| 2025-10-17 | DGilbert Cisneros | BUY | $1K – $15K | 33d |
| 2025-10-17 | DGilbert Cisneros | BUY | $1K – $15K | 32d |
| 2025-10-28 | RKevin Hern | SELL | $15K – $50K | 20d |
| 2025-10-28 | RKevin Hern | SELL | $15K – $50K | 19d |
| 2025-10-07 | DRo Khanna | SELL | $1K – $15K | 30d |
| 2025-10-28 | RKevin Hern | PARTIAL_SELL | $15K – $50K | 1d |
| 2025-09-23 | DValerie Hoyle | SELL | $1K – $15K | 17d |
| 2025-09-23 | DValerie Hoyle | SELL | $1K – $15K | 17d |
| 2025-08-04 | RLisa McClain | SELL | $1K – $15K | 42d |
| 2025-08-04 | RLisa McClain | SELL | $1K – $15K | 39d |
| 2024-10-29 | DValerie Hoyle | BUY | $1K – $15K | 318d |
| 2025-07-31 | DGilbert Cisneros | SELL | $1K – $15K | 15d |
| 2025-07-31 | DGilbert Cisneros | SELL | $1K – $15K | 14d |
| 2024-12-11 | RLisa McClain | BUY | $1K – $15K | 245d |
| 2025-07-31 | DGilbert Cisneros | PARTIAL_SELL | $1K – $15K | 13d |
| 2025-06-26 | DGilbert Cisneros | SELL | $1K – $15K | 15d |
| 2025-06-11 | DGilbert Cisneros | SELL | $1K – $15K | 30d |
| 2025-06-26 | DGilbert Cisneros | SELL | $1K – $15K | 14d |
| 2025-06-11 | DGilbert Cisneros | SELL | $1K – $15K | 29d |
| 2025-06-11 | DGilbert Cisneros | PARTIAL_SELL | $1K – $15K | 27d |
| 2025-06-26 | DGilbert Cisneros | PARTIAL_SELL | $1K – $15K | 12d |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 42d |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 41d |
| 2025-05-13 | DGilbert Cisneros | SELL | $1K – $15K | 27d |
| 2025-05-13 | DGilbert Cisneros | SELL | $1K – $15K | 24d |
| 2025-04-21 | RBruce Westerman | SELL | $1K – $15K | 22d |
| 2025-04-23 | DRo Khanna | BUY | $1K – $15K | 19d |
| 2025-04-21 | RBruce Westerman | SELL | $1K – $15K | 21d |
| 2025-04-28 | DGilbert Cisneros | SELL | $1K – $15K | 9d |
| 2025-04-28 | DGilbert Cisneros | SELL | $1K – $15K | 8d |
| 2025-03-03 | RBruce Westerman | BUY | $1K – $15K | 44d |
| 2025-03-12 | DRo Khanna | BUY | $1K – $15K | 29d |
| 2025-03-06 | DRo Khanna | SELL | $1K – $15K | 35d |
| 2025-03-17 | DGilbert Cisneros | SELL | $1K – $15K | 21d |
| 2025-02-13 | RJohn Boozman | BUY | $1K – $15K | 22d |
| 2025-02-24 | DGilbert Cisneros | SELL | $1K – $15K | 10d |
| 2025-02-19 | DRo Khanna | BUY | $1K – $15K | 15d |
| 2025-02-13 | RJohn Boozman | BUY | $1K – $15K | 21d |
| 2025-02-24 | DGilbert Cisneros | PARTIAL_SELL | $1K – $15K | 8d |
| 2025-01-17 | DRo Khanna | SELL | $1K – $15K | 20d |
| 2024-04-24 | RMichael McCaul | SELL | $50K – $100K | 17d |
| 2024-04-23 | RMichael McCaul | SELL | $50K – $100K | 18d |
| 2024-04-23 | RMichael McCaul | SELL | $100K – $250K | 18d |
| 2024-04-12 | RMichael McCaul | SELL | $15K – $50K | 29d |
| 2024-04-12 | RMichael McCaul | SELL | $1K – $15K | 29d |
| 2023-05-30 | DLois Frankel | BUY | $1K – $15K | 23d |
| 2023-05-31 | DLois Frankel | PARTIAL_SELL | $1K – $15K | 22d |
| 2023-04-19 | DLois Frankel | PARTIAL_SELL | $1K – $15K | 30d |
| 2023-05-01 | DLois Frankel | PARTIAL_SELL | $1K – $15K | 18d |
| 2023-04-26 | RJohn Curtis | PARTIAL_SELL | $1K – $15K | 6d |
| 2023-03-29 | DLois Frankel | PARTIAL_SELL | $1K – $15K | 30d |
| 2023-02-23 | RJohn Curtis | PARTIAL_SELL | $1K – $15K | 13d |